Ji Yeoun Yoo, MD
Assistant Professor AdjunctAbout
Research
Publications
2024
Elevated phase amplitude coupling as a depression biomarker in epilepsy
Young J, Chan A, Jette N, Bender H, Saad A, Saez I, Panov F, Ghatan S, Yoo J, Singh A, Fields M, Marcuse L, Mayberg H. Elevated phase amplitude coupling as a depression biomarker in epilepsy. Epilepsy & Behavior 2024, 152: 109659. PMID: 38301454, PMCID: PMC10923038, DOI: 10.1016/j.yebeh.2024.109659.Peer-Reviewed Original ResearchBeck Depression Inventory-IIPhase-amplitude couplingComorbid depressionAssessment of depressive symptomsBeck Depression Inventory-II scoresAssociated with comorbid depressionAnterior cingulate cortexEpilepsy patientsAmplitude couplingPre-operative assessmentElevated phase-amplitude couplingSpectral powerOrbitofrontal cortexCingulate cortexPrimary depressionCase-control comparisonDepressive symptomsBrain regionsBrain activityDepression biomarkersAdult epilepsy patientsDepressionBrain recordingsPatient studiesTreatment targetProvider Experience With the Use of Ketamine for Refractory Status Epilepticus
Tantillo G, Davis N, Granstein J, Yoo J, Agarwal P, Reilly K, Reynolds A, Kayal G, Liang J, Jetté N. Provider Experience With the Use of Ketamine for Refractory Status Epilepticus. Clinical Neuropharmacology 2024, 47: 37-43. PMID: 38478363, DOI: 10.1097/wnf.0000000000000582.Peer-Reviewed Original ResearchConceptsRefractory status epilepticusStatus epilepticusPerceived contraindicationsUse of vasopressorsFirst-line agentsRefractory status epilepticus treatmentSecond-line agentsAssociated with complicationsElevated intracranial pressureNeurocritical Care SocietyRespiratory depressionHeart failureEEG monitoringHemodynamic supportOptimal doseKetamine useSeizure controlIntracranial pressureControl seizuresDecreased needKetamine usersAmerican Epilepsy SocietyKetamineAmerican AcademyAnesthetic agentsHealth care access, psychosocial outcomes and mental health in adults living with epilepsy during the COVID-19 pandemic
Mc Carthy L, Mathew B, Blank L, Van Hyfte G, Gotlieb E, Goldstein J, Agarwal P, Kwon C, Singh A, Fields M, Marcuse L, Yoo J, Sivarak E, Gururangan K, Navis A, Jetté N. Health care access, psychosocial outcomes and mental health in adults living with epilepsy during the COVID-19 pandemic. Epilepsy & Behavior 2024, 151: 109617. PMID: 38219607, DOI: 10.1016/j.yebeh.2023.109617.Peer-Reviewed Original ResearchConceptsPatient Health Questionnaire-9Generalized Anxiety Disorder-7Psychosocial outcomesMental healthHealthcare accessCancelled visitsCross-sectional study of adultsHealth care accessCOVID-19 pandemicMental health comorbiditiesPoor mental healthSocial support issuesPoor psychosocial outcomesSymptoms of anxietyCross-sectional studyStudy of adultsCare accessPsychosocial supportHealth comorbiditiesModerate/severe depressionHealth systemTelehealth visitsNeurological carePLWEStandardized questionnaire
2021
Analysis of Brief Potentially Ictal Rhythmic Discharges (BIRDs) and seizures in Epilepsy Patients with Responsive Neurostimulation undergoing Scalp Electroencephalography (2982)
Lemus H, Jette N, Fields M, Bolden D, Yoo J. Analysis of Brief Potentially Ictal Rhythmic Discharges (BIRDs) and seizures in Epilepsy Patients with Responsive Neurostimulation undergoing Scalp Electroencephalography (2982). Neurology 2021, 96 DOI: 10.1212/wnl.96.15_supplement.2982.Peer-Reviewed Original Research
2020
The Effects of Paternal Seizure Disorders and Antiseizure Medication Use on Offspring Neurodevelopmental Outcomes, Psychiatric Comorbidities, and Sexual Health. (4262)
Esquivel H, Casale M, Young J, Marcuse L, Yoo J, Mueller B, Fields M. The Effects of Paternal Seizure Disorders and Antiseizure Medication Use on Offspring Neurodevelopmental Outcomes, Psychiatric Comorbidities, and Sexual Health. (4262). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.4262.Peer-Reviewed Original Research
2019
Early Use of Vagal Nerve Stimulation (VNS) in a Patient with New Onset Refractory Status Epilepticus (NORSE) (P5.5-032)
Wong B, Yoo J, Fields M. Early Use of Vagal Nerve Stimulation (VNS) in a Patient with New Onset Refractory Status Epilepticus (NORSE) (P5.5-032). Neurology 2019, 92 DOI: 10.1212/wnl.92.15_supplement.p5.5-032.Peer-Reviewed Original Research
2016
A Quality of Care Analysis Utilizing the 2014 American Academy of Neurology Updated Quality Measurement Set for Patients with Epilepsy (P1.067)
Lai G, Wolf S, McGoldrick P, Lee K, Gao W, Yoo J, Kepecs M, Harden C. A Quality of Care Analysis Utilizing the 2014 American Academy of Neurology Updated Quality Measurement Set for Patients with Epilepsy (P1.067). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.p1.067.Peer-Reviewed Original Research